Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Declines By 97.3%

GlucoTrack, Inc. (NASDAQ:GCTK) saw a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 32,900 shares, a decline of 97.3% from the January 15th total of 1,220,000 shares. Approximately 0.5% of the company’s shares are short sold. Based on an average trading volume of 3,070,000 shares, the short-interest ratio is currently 0.0 days.

Institutional Trading of GlucoTrack

An institutional investor recently raised its position in GlucoTrack stock. Geode Capital Management LLC boosted its position in shares of GlucoTrack, Inc. (NASDAQ:GCTK) by 315.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 112,787 shares of the company’s stock after buying an additional 85,626 shares during the quarter. Geode Capital Management LLC owned approximately 14.10% of GlucoTrack worth $42,000 as of its most recent filing with the Securities & Exchange Commission. 10.92% of the stock is currently owned by institutional investors.

GlucoTrack Price Performance

Shares of GCTK stock opened at $0.53 on Thursday. The business has a 50-day moving average of $3.51 and a 200 day moving average of $24.47. GlucoTrack has a 1-year low of $0.49 and a 1-year high of $99.00. The stock has a market capitalization of $424,320.00, a PE ratio of -0.01 and a beta of -0.38.

About GlucoTrack

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.